이엔셀

456070· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩6,140+7.91%

2026-08-04

Financials

Valuation Metrics

이엔셀's Market Cap is ₩677B. At end of 2025 it was ₩2005B. Ranked #1516 of 2,436 in KR market (top 62%), #875 of 1,649 on KOSDAQ (top 53%), #168 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 72%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	67.72B KRW	KR#1,516/2,436 Sec#168/234
Revenue	4.47B KRW	KR#2,353/2,436 Sec#200/234
Net Income	-16.72B KRW	KR—/2,436 Sec—/234
Total Assets	60.36B KRW	KR#2,081/2,436 Sec#182/234
Net Assets	34.96B KRW	KR#2,102/2,436 Sec#182/234
Value
P/B	1.94x	KR#1,930/2,436 Sec#141/234
P/S	15.14x	KR#2,314/2,436 Sec#175/234
FCF Yield	-19.70%	KR—/2,436 Sec—/234
Profitability
ROE	-47.83%	KR#2,262/2,436 Sec#197/234
ROA	-27.70%	KR#2,280/2,436 Sec#191/234
Op. Margin	-402.47%	KR#2,367/2,436 Sec#202/234
Revenue Growth	-71.75%	KR#2,329/2,436 Sec#208/234
Financial Health
Debt Ratio	172.65%	KR#1,465/2,436 Sec#166/234
Total Debt	9.24B KRW	KR#1,648/2,436 Sec#150/234
FCF	-13.34B KRW	KR#1,799/2,436 Sec#160/234
Cash	24.44B KRW	KR#1,123/2,436 Sec#80/234
Current Ratio	9.07x	KR#118/2,436 Sec#31/234
Performance
1Y Return	-45.90%	KR#1,985/2,436 Sec#182/234
1M Return	-16.01%	KR#2,055/2,436 Sec#204/234
From 52W High	-70.69%	KR#2,158/2,436 Sec#199/234
1Y MDD	-75.66%	KR#2,174/2,436 Sec#199/234
Trading
Volume	42,713 shares	KR#1,443/2,436 Sec#144/234
Foreign Own.	3.60%	KR—/2,436 Sec—/234
Per Share
EPS	-1,531 KRW	KR—/2,436 Sec—/234
BPS	3,178 KRW	KR#1,779/2,436 Sec#138/234